Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: The heart and estrogen/progestin replacement study

Circulation

Volumn 102, Issue 18, 2000, Pages 2228-2232

  Hsia, Judith ^a,h   Simon, Joel A ^b,c   Lin, Feng ^c   Applegate, William B ^d   Vogt, Molly T ^e   Hunninghake, Donald ^f   Carr, Margaret ^g  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g WYETH AYERST RESEARCH   (United States)

^h NONE   (United States)

Author keywords

Coronary disease; Hormones; Peripheral vascular disease; Women

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTIOXIDANT; CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PERIPHERAL VASCULAR DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034739442     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.18.2228     Document Type: Article

References (27)

1. Mortality over a period of 10 years in patients with peripheral arterial disease
2. The prevalence of peripheral arterial disease in a defined population
3. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: A randomized controlled clinical trial
4. Effect of lovastatin on early carotid atherosclerosis and cardio-vascular events
5. Effects of lowering average or below-average cholesterol levels on the progression of carotid atherosclerosis: Results of the LIPID Athcrosclerosis Substudy
6. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)
7. Kuopio Atherosclerosis Prevention Study (KAPS): A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries
8. Reduction of stroke incidence after myocardial infarction with pravastatin: The Cholesterol and Recurrent Events (CARE) study
9. The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)
10. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: A report of the Regression Growth Evaluation Statin Study (REGRESS)
11. Chelation therapy for intermittent claudication A double-blind, randomized, controlled trial
12. Cilostazol has beneficial effects in treatment of intermittent claudication: Results from a multicenter, randomized, prospective, double-blind trial
13. Cilostazol or pentoxifylline for claudication?
14. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events
15. Current estrogen-progestin and estrogen replacement therapy in elderly women: Associaton with carotid atherosclerosis
16. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women
17. Heart and Estrogen/Progestin Replacement Study (HERS): Design, methods and baseline characteristics
18. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
19. The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease
20. Predictors of the presence and extent of peripheral arterial occlusive disease
21. Intermittent claudication, heart disease risk factors, and mortality: The Whitehall Study
22. A prospective study of obesity and risk of coronary heart disease in women
23. Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women
24. The epidemiology of serum sex hormones in postmenopausal women
25. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated Vasodilatation in postmenopausal women with coronary heart disease
26. Third generation oral contraceptives and risk of myocardial infarction: An international case-control study
27. Design of the Women's Health Initiative Clinical Trial and Observational Study